World of DTC Marketing

MARCH 10, 2022

The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. AbbVie significantly inflated prices over the past two decades for patients in the U.S. The executives at AbbVie make over $300 million.

Prescription 205

Prescription Pharmaceutical products Pharmaceutical Marketing 205

InCrowd

AUGUST 17, 2023

Prescriber Perspectives on Weight Loss Drugs in 2023 Examine how healthcare professionals (HCPs) view and prescribe weight loss drugs currently on the market in our new Instant Insights report. Download the report today. The post Instant Insights – Weight Loss Drugs appeared first on InCrowd.

Prescription 130

Prescription Physicians Management Healthcare 130

pharmaphorum

JANUARY 9, 2023

This Nine for 2023 three-part series will argue that, this year, the future-facing Janus prediction of unprecedented and transformative change is true. However, the pandemic is only one of the often deep-rooted forces that will come together in 2023 to exert transformative pressure on healthcare.

Medicine 98

Medicine Healthcare Healthcare Pharma 98

Pharmaceutical Technology

MAY 30, 2023

According to GlobalData’s Looking Ahead to 2023 – the Future of Pharma report, five drugs set for approval in 2023 are projected to attain blockbuster status or near-blockbuster status by 2028 with US company dominance. These drugs are set to make a combined $4.34bn in sales in 2028. Similarly, Almirall S.A.,

Sales 105

Sales Marketing Prescription Pharma 105

pharmaphorum

DECEMBER 22, 2022

The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways. We can now measure patient activity, steps, and movement continuously and in real time, which serves as a new potential indicator of treatment effectiveness.

FDA 97

FDA Patients Electronics Medical 97

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 98

Medicine Healthcare Healthcare Manufacturing 98

PM360

MAY 15, 2023

As the company grew their patient services offerings, Laura has spearheaded the creation of many solutions which have driven sales into hundreds of brands over the last 13 years. Laura has educated the new ConnectiveRx employees on the “real” patient journey. Interestingly, her approach was not only shaped by professional aptitude.

Sales 94

Sales Pharma sales reps Prescription Recruitment 94

Nixon Gwilt Law

FEBRUARY 27, 2023

Late Friday (February 24, 2023), the US Drug Enforcement Agency (DEA) released a proposed rule to make permanent some of the flexibilities allowed during the Public Health Emergency (PHE) for telemedicine companies whose providers prescribe controlled substances.

Prescription 105

Prescription Medical Patients Specialization 105

PM360

JULY 13, 2023

PM360 asked experts in helping patients stay on their prescribed therapies about where the industry could make the biggest improvements and how to better detect potential barriers. How can the industry better monitor and detect potential barriers to adherence for individual patients? How can they improve?

Medical 98

Medical Patients Education Transportation 98

PM360

JULY 13, 2023

“Drugs don’t work in patients who don’t take them,” C. 2021 revealed that roughly one in four prescriptions were never filled. 1 In addition, of patients who began therapy, more than 70% were no longer on their prescribed medication after 12 months. 2021 revealed that roughly one in four prescriptions were never filled.

Patients 98

Patients Side effects Insurance Medical 98

PM360

DECEMBER 14, 2023

Survey any physician if they’ve been asked by a patient about a prescription weight loss medication and you’ll hear a resounding “yes.” The recent Sermo Barometer confirms that 89% of 300+ global practitioners have seen an increase in patients proactively requesting prescription weight loss medications.

Medical 105

Medical Side effects Physicians Prescription 105

World of DTC Marketing

MARCH 17, 2021

sales until at least 2023 because 257 patent filings stand in the way. Billions in excess drug costs are shouldered by employers, taxpayers and patients as a result. There are too many people within the industry who understand that patients are people, not just customers and prospects.

Pharma 186

Pharma Competition Prescription Sales 186

World of DTC Marketing

MAY 19, 2021

SUMMARY: “You’re spending all this money to make sure you make money rather than spending money to… help patients,” the California congresswoman told AbbVie’s, Richard Gonzalez. Pharmaceutical company AbbVie significantly inflated prices over the past two decades for patients in the U.S. But it get worse.

Pharma 181

Pharma Prescription Patients Pharmaceutical 181

PM360

APRIL 7, 2023

Reduced patient out-of-pocket (OOP) costs in Part D have the potential to reduce beneficiary reliance on foundation support, with commensurate reductions in manufacturer donations required. The business-to-business market leaders must find new and creative ways to help patients receive their treatments.

Manufacturing 97

Manufacturing Insurance Marketing Government 97

PM360

NOVEMBER 12, 2023

Technological innovations and changes in consumer behavior over the past 10 years have reduced friction, saved time, and opened new options for consumers and patients seeking routine prescriptions and refills via telehealth. Let’s face it, most consumers seek convenience wherever they can find it.

Prescription 52

Prescription Media Pharma Patients 52

Pharmaceutical Technology

MAY 25, 2023

ATI-1501 has been designed to enable the wider use of metronidazole in patients who have difficulty swallowing. The US Food and Drug Administration has set 23 September 2023 as the prescription drug user fee action date for ATI-1501.

Food and Drug Administration 105

Food and Drug Administration Prescription Food Marketing 105

PM360

NOVEMBER 21, 2024

Because the signs and symptoms of endogenous hypercortisolism often masquerade as those of other conditions, patients often go undiagnosed for between five and ten years, leading to significantly increased morbidity and mortality.

Marketing 52

Marketing Education Prescription Pharmaceutical 52

Pharmaceutical Technology

MAY 26, 2023

This 691-patient study was conducted in Europe, the US, Japan and Australia. Today’s acceptance marks a significant advancement towards the goal of providing patients with previously treated metastatic colorectal cancer a much-needed therapeutic option, given the limited treatment options currently available to patients.”

Food and Drug Administration 105

Food and Drug Administration FDA Prescription Food 105

PM360

MAY 21, 2024

Navigating the complex healthcare system can be a stressful experience for patients, from obtaining a diagnosis to finding the right specialty care or treatment. To help alleviate some of the challenges patients face, it’s crucial to meet them with personalized resources that fit their needs at different stages throughout their journey.

Patients 52

Patients Prescription Side effects Doctors 52

MedReps

JANUARY 30, 2023

Medical Sales Trends to Watch Out For in 2023 If you want to know what the future holds and create some forward-thinking sales goals, then check out these medical sales trends to watch out for in 2023. Along with an increase in elderly people, there’s also more healthcare spending taking place. Some are located throughout the world.

Medical sales 74

Medical sales Medical Sales Sales goal 74

Pharmaceutical Technology

JUNE 21, 2023

The regulatory approval was based on the findings obtained from a double-blind, multinational, placebo-controlled, randomised clinical trial conducted in 5,522 chronic coronary disease patients. We are dedicated to addressing heart disease, the leading cause of death, by ensuring all patients have access to LODOCO.”

Food and Drug Administration 98

Food and Drug Administration FDA Prescription Food 98

PM360

AUGUST 9, 2022

How can we help ensure patients continue to take their medications as prescribed? The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue. But it is not a simple answer. Furthermore, it is estimated to reach $6.5 Vincent Keunen.

Prescription 105

Prescription Medical Patients Side effects 105

PharmExec

APRIL 14, 2023

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Pharma 52

Pharma Prescription Leads Patients 52

Pharmaceutical Technology

MAY 2, 2023

The regulatory body has also granted priority review to the application and set 28 August 2023 as a target date for the prescription drug user fee act (PDUFA). The European Medicines Agency (EMA) has also validated the Type II variation application for Reblozyl.

Food and Drug Administration 98

Food and Drug Administration FDA Safety Prescription 98

PM360

MAY 15, 2023

Karina Castagna SVP Access and Adherence OptimizeRx Advancing Digital Access at Point-of-Care Karina Castagna believes every life sciences company must have digital omnichannel as a key pillar in its marketing and access strategy for point of care (POC) and point of prescribe to better serve both providers and patients.

Physicians 59

Physicians Electronics Manufacturing Prescription 59

PM360

OCTOBER 13, 2023

HCPs need pharma, and pharma needs HCPs—so let’s make sure that this next chapter of engagement is one of partnership, in pursuit of the interest of patients.” Only 15% of prescribers think the drugs come at reasonable cost to patients or have decent insurance coverage eligibility.

Healthcare 59

Healthcare Healthcare Doctors Pharma 59

Pharmaceutical Technology

MARCH 17, 2023

As the field of digital therapeutics continues to broaden, specific uses in mental health and neurology are increasingly making headway for patients and on the market. In contrast, non-prescription digital therapeutics do not need clinical data to enter the market, says Wasden, adding that evidence from observational studies suffices.

Prescription 111

Prescription Pharmacology Medical Pharma 111

European Pharmaceutical Review

OCTOBER 17, 2024

These factors may increase the likelihood that patients and caregivers carry it regularly. 8 An additional study in patients experiencing anaphylaxis symptoms following an oral food challenge demonstrated that neffy reversed anaphylaxis symptoms within the same timeframe typically observed for injection products. Lowenthal R.

Food and Drug Administration 121

Food and Drug Administration Medicine Consulting Food 121

Eversana Intouch

JANUARY 19, 2023

Success in 2023 will mean addressing each of those five issues meaningfully – understanding them fully and giving them real action, not just lip service. Pharma marketers in 2023 need to: Look for blind spots. Each year, we forecast several trends that will influence life-sciences marketing the most in the months to come ahead.

Medical 52

Medical Education Competition Marketing 52

PM360

JULY 13, 2023

Here are twelve of the best examples of programs, strategies, solutions, technology, and more that companies have developed or are using to keep patients on their prescribed therapies. But outdated manual processes are complex and leave many patients out. But outdated manual processes are complex and leave many patients out.

Education 89

Education Medical Patients Media 89

Pharmaceutical Technology

JUNE 20, 2023

Everyone at Santhera has been working diligently to advance vamorolone in order to make this important treatment option available to patients. The US FDA has assigned 26 October 2023 as the Prescription Drug User Fee Act (PDUFA) date for its decision.

Food and Drug Administration 98

Food and Drug Administration FDA Prescription Medicine 98

Pharmaceutical Technology

JUNE 19, 2023

The FDA will make an approval decision by the new Prescription Drug User Fee Act (PDUFA) target action date of 16 September 2023. The reason for this review extension was undisclosed in the announcement. In July 2022, GSK acquired the therapy as part of its $1.9bn acquisition of Sierra Oncology.

Food and Drug Administration 98

Food and Drug Administration FDA Prescription Food 98

pharmaphorum

NOVEMBER 2, 2022

Lilly’s head of diabetes, Mike Mason, said on the company’s results call that the rollout of Mounjaro (tirzepatide) was “really unprecedented” for a new diabetes therapy in the US, and had been driven by “tremendous patient satisfaction and the visible results that people experience.”

Sales 105

Sales FDA Distribution Prescription 105

European Pharmaceutical Review

JANUARY 25, 2024

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. It emphasises its ability to make information interoperable with electronic health systems such as e-prescription and electronic health records.

Healthcare 98

Healthcare Healthcare Safety Electronics 98

PM360

DECEMBER 14, 2022

that didn’t stop us from asking 10 industry experts to take their best shot at anticipating what to expect in 2023 and beyond. So, in order to help best prepare you for what might come, we asked these 10 individuals to peer into their crystal balls and let us know: What will be the biggest trend(s) marketers will be talking about in 2023?

Marketing 91

Marketing Patients Healthcare Healthcare 91

PM360

JULY 26, 2023

Transition to a Bigger Role in Clinical Healthcare Because pharmacies were part of essential services during COVID-19, staying open when many businesses couldn’t, they became a key resource for patients for treatments, prevention, and protection. They process prescriptions and vaccines, and, in some states, they sometimes administer vaccines.

Retail 98

Retail Healthcare Healthcare Consulting 98

Healthcare Success

NOVEMBER 7, 2022

They’re researching key trends that will attract new high-intent audiences, increase engagement, drive revenue, and reinforce patient loyalty in 2023. In this article, you’ll learn: 4 Advertising Planning Strategies for 2023 6 Marketing Strategies That Outpace Market Disruption. 4 Advertising Planning Strategies for 2023.

Marketing 52

Marketing Media Healthcare Healthcare 52